Nadia Harbeck

Nadia Harbeck

Kerpener Str. 34
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 702 publications

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

Journal: JCO precision oncology

Published: September 04, 2026

A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.

A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.

Journal: Cancers

Published: June 01, 2026

Innovative treatment approaches for early-stage breast cancer

Innovative treatment approaches for early-stage breast cancer

Journal: MMW Fortschritte der Medizin

Published: May 28, 2026

Innovative treatment approaches for metastatic breast cancer

Innovative treatment approaches for metastatic breast cancer

Journal: MMW Fortschritte der Medizin

Published: May 28, 2026

Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 18, 2026

AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

Journal: Breast (Edinburgh, Scotland)

Published: April 29, 2026

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 24, 2026

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL.

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL.

Journal: ESMO real world data and digital oncology

Published: April 20, 2026

HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.

HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.

Journal: ESMO open

Published: April 11, 2026

New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice.

New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice.

Journal: Breast (Edinburgh, Scotland)

Published: April 08, 2026

Early local immune activation following intra-operative radiotherapy in human breast tissue.

Early local immune activation following intra-operative radiotherapy in human breast tissue.

Journal: Oncoimmunology

Published: April 07, 2026

Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 24, 2026

Showing 1-12 of 702

Last Updated: 09/26/2026